Literature DB >> 16807647

Interleukin-10 promoter polymorphism and venous thrombosis: a case-control study.

Eva Cochery-Nouvellon1, Fabien Vitry, Pascale Cornillet-Lefebvre, Nathalie Hezard, Lucile Gillot, Philippe Nguyen.   

Abstract

The human interleukin-10 promoter gene is highly polymorphic. IL-10 polymorphisms have been associated with various autoimmune and lymphoproliferative disorders. Although IL-10 has been shown to modulate thrombin generation in several experimental models, it is not known whether IL-10 polymorphisms could be a risk factor for venous thrombosis. We therefore conducted a case-control study comparing 74 consecutive patients who experienced at least one episode of documented venous thromboembolic event and 100 healthy controls. All subjects were Caucasians. Five polymorphisms of the IL-10 promoter gene were studied: two highly polymorphic dinucleotide repeats, IL-10 R and IL-10G, and three single nucleotide polymorphisms at position -1082, -819 and -592. Factor VG1691C Leiden mutation was systematically determined. Multivariate logistic regression analysis showed that IL-10 G13 and G10 alleles are independent risk factors for venous thrombosis (Odds ratio:OR = 3.33, p = 0.003 and OR = 2.83, p = 0.03, respectively). Furthermore, IL-10 G10 allele is more frequent in recurrent disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807647     DOI: 10.1160/TH06-01-0027

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.

Authors:  Robert Y L Zee; Vadim Bubes; Sanjay Shrivastava; Paul M Ridker; Robert J Glynn
Journal:  Clin Chim Acta       Date:  2009-04       Impact factor: 3.786

2.  Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study.

Authors:  A P Reiner; L A Lange; N L Smith; N A Zakai; M Cushman; A R Folsom
Journal:  J Thromb Haemost       Date:  2009-06-22       Impact factor: 5.824

3.  Novel Biomarkers Associated with Deep Venous Thrombosis: A Comprehensive Review.

Authors:  Dawn M Barnes; Thomas W Wakefield; John E Rectenwald
Journal:  Biomark Insights       Date:  2008-01-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.